SPONSOR
Sellas Life Sciences Group
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Hematologic Malignancies
Sellas Life Sciences Group is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Hematologic Malignancies.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sellas Life Sciences Group
How many clinical trials has Sellas Life Sciences Group sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Sellas Life Sciences Group, of which 1 are actively recruiting participants. These trials cover conditions including Hematologic Malignancies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sellas Life Sciences Group research focus on?
Sellas Life Sciences Group clinical trials span Hematologic Malignancies. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sellas Life Sciences Group clinical trial?
To participate in a Sellas Life Sciences Group trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sellas Life Sciences Group trials with current recruitment status updated daily.
Clinical Trials by Sellas Life Sciences Group
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology